Recent News

• 10.06.2025 - REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD
• 10.06.2025 - REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD
• 09.29.2025 - REGENXBIO Announces Presentation at the World Muscle Society
• 09.29.2025 - REGENXBIO Announces Presentation at the World Muscle Society
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - Baird 2025 Global Healthcare Conference
• 09.09.2025 - Baird 2025 Global Healthcare Conference
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference

Recent Filings

• 10.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.10.2025 - 144 Report of proposed sale of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities